Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  2. 타비 시술을 위한 CT 평가
  3. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  4. FFR is a Routine Cath Lab Procedure
  5. FFR, It\'s Standard
  6. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  7. Updated Imaging/Physiology-Guided PCI Tuning 2021
  8. Under Pressure: Optimal Post-Dilation Strategy
  9. Difficult Wiring, Tips and Tricks
  10. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  11. Imaging-guided PSP for Optimizing PCI
  12. How to Treat Tandem Lesion Under Physiology-Guidance
  13. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  14. Post TAVR Coronary Access with Evolut System
  15. Self-Expandable Evolut R & PRO Valve
  16. TAVR for Bicuspid AV: Tips and Tricks
  17. Bifurcation PCI: Contemporary Practical Approach
  18. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  19. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  20. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  21. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  22. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  23. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  24. Current Status of Balloon-Expandable TAVR in Korea
  25. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  26. TAVR for Bicuspid AV: Tips and Tricks
  27. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  28. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  29. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  30. Expert Case Review: Complex Bifurcation PCI
  31. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  32. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  33. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  34. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  35. How About Integrated Use of Resting Pd/Pa and FFR?
  36. Distal Left Main Bifurcation PCI: Concept Is More Important.
  37. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  38. FFR as the Gold Standard Index!
  39. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  40. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  41. Asian Pacific TAVR Registry
  42. [Taped Case] TAVR with Evolut R
  43. Bicuspid AS: Future Perspectives of TAVR
  44. Integrated Use of FFR and IVUS for LM PCI
  45. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  46. Bicuspid and Valve-in-Valve; How Different?
  47. Clinical Outcome of DEFER
  48. Left Main and MVD PCI: Imaging and Functional Guidance
  49. Utility of Intravascular Imaging for Resolving Issues During PCI
  50. Long Lesion and Tandem Lesion
  51. Bicuspid TAVR Registry
  52. AP TAVR Registry
  53. Current Status of TAVR: High/Intermediate and Lower Risk
  54. Clinical Impact of Routine FFR Measurement
  55. Tandem
  56. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  57. Practical Aspect of IMR in AMI and Stable Angina
  58. Fate of FFR-Guided Deferral Data from IRIS-FFR Registry
  59. Elderly Population
  60. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  61. [Review in 2015] Physiology
  62. Tandem Lesion Evaluation
  63. Integrated Use of IVUS and FFR in Real Practice
  64. Readmission After PCI or CABG
  65. Left Main
  66. Final Answer RESTORE
  67. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  68. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  69. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  70. Preliminary Data from IRIS FFR Registry
  71. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  72. Left Main PCI
  73. Understanding About Visual-Functional Mismatching
  74. TAVI for Bicuspid Valve Stenosis
  75. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  76. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  77. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main Disease: 3-year Follow-up of the PRECOMBAT Trial
  78. Clinical Implementation of FFR
  79. Case-based Review: Incidence and Treatment of LM ISR
  80. LM & Tandem Lesion
  81. VH IVUS: Native Plaque and Neointima
  82. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  83. LM PCI
  84. IRIS-ELEMENT Data Review
  85. Cross and Perfect: 2013 Update
  86. Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry
  87. Anatomical - Functional Stenosis: How Much Discordant?
  88. Case Presentation: Functional Angioplasty
  89. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  90. Novice's Trial of Complex LM PCI
  91. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  92. FFR Utilization in LM PCI
  93. Promus Element Clinical Program in Asan Medical Center
  94. FFR-guided PCI in Tandem Lesion
  95. Two Cases with Coronary Thromboembolism
  96. FFR Guided Functional Angioplasty
  97. Does the Timing of IABP Matter?